APO RESEARCH · REPORT
Peptide Therapeutics
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
Product & engineering
Understand the product.
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
Selected research
Industry Growth & Trends
Global Peptide Therapeutics Industry Growth and Trends Forecast to 2032
Market perspective
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
According to APO Research, the global Peptide Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Peptide Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Peptide Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptide Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptide Therapeutics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Peptide Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Peptide Therapeutics Market by Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Peptide Therapeutics Segment by Type
Injection
Oral
Other
Peptide Therapeutics Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
Peptide Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Peptide Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Oral
- Other
Applications
- Cancer
- Metabolic Disorders
- Central Nervous System
- Other
Companies covered
- Sanofi
- Teva
- Novo Nordisk
- Takeda
- Eli Lilly
- AstraZeneca
- Novartis
- AbbVie
- Ipsen
- Ferring
- Merck
- The Medicines
- J & J
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Peptide Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Peptide Therapeutics Market Size by Region (2021-2032)
- 1.4.1 Global Peptide Therapeutics Market Size by Region (2021-2026)
- 1.4.2 Global Peptide Therapeutics Market Size by Region (2027-2032)
- 1.5 Key Regions Peptide Therapeutics Market Size (2021-2032)
- 1.5.1 North America Peptide Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Peptide Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Peptide Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Peptide Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Peptide Therapeutics Market Size Growth Rate (2021-2032)
2 Peptide Therapeutics Market by Type
- 2.1 Type Introduction
- 2.1.1 Injection
- 2.1.2 Oral
- 2.1.3 Other
- 2.2 Global Peptide Therapeutics Market Size by Type
- 2.2.1 Global Peptide Therapeutics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Peptide Therapeutics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Peptide Therapeutics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Peptide Therapeutics Market Size by Regions
- 2.3.1 North America Peptide Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Peptide Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Peptide Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Peptide Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Peptide Therapeutics Market Size Breakdown by Type (2021-2026)
3 Peptide Therapeutics Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer
- 3.1.2 Metabolic Disorders
- 3.1.3 Central Nervous System
- 3.1.4 Other
- 3.2 Global Peptide Therapeutics Market Size by Application
- 3.2.1 Global Peptide Therapeutics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Peptide Therapeutics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Peptide Therapeutics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Peptide Therapeutics Market Size by Regions
- 3.3.1 North America Peptide Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Peptide Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Peptide Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Peptide Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Peptide Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Peptide Therapeutics Industry Trends
- 4.2 Peptide Therapeutics Industry Drivers
- 4.3 Peptide Therapeutics Industry Opportunities and Challenges
- 4.4 Peptide Therapeutics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Peptide Therapeutics Revenue (2021-2026)
- 5.2 Global Peptide Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Peptide Therapeutics Key Company Headquarters & Area Served
- 5.4 Global Peptide Therapeutics Company, Product Type & Application
- 5.5 Global Peptide Therapeutics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Peptide Therapeutics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Peptide Therapeutics Players Market Share by Revenue in 2025
- 5.6.3 2025 Peptide Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Sanofi Peptide Therapeutics Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Teva Peptide Therapeutics Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Novo Nordisk
- 6.3.1 Novo Nordisk Company Information
- 6.3.2 Novo Nordisk Business Overview
- 6.3.3 Novo Nordisk Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Novo Nordisk Peptide Therapeutics Product Portfolio
- 6.3.5 Novo Nordisk Recent Developments
- 6.4 Takeda
- 6.4.1 Takeda Company Information
- 6.4.2 Takeda Business Overview
- 6.4.3 Takeda Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Takeda Peptide Therapeutics Product Portfolio
- 6.4.5 Takeda Recent Developments
- 6.5 Eli Lilly
- 6.5.1 Eli Lilly Company Information
- 6.5.2 Eli Lilly Business Overview
- 6.5.3 Eli Lilly Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Eli Lilly Peptide Therapeutics Product Portfolio
- 6.5.5 Eli Lilly Recent Developments
- 6.6 AstraZeneca
- 6.6.1 AstraZeneca Company Information
- 6.6.2 AstraZeneca Business Overview
- 6.6.3 AstraZeneca Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 AstraZeneca Peptide Therapeutics Product Portfolio
- 6.6.5 AstraZeneca Recent Developments
- 6.7 Novartis
- 6.7.1 Novartis Company Information
- 6.7.2 Novartis Business Overview
- 6.7.3 Novartis Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Novartis Peptide Therapeutics Product Portfolio
- 6.7.5 Novartis Recent Developments
- 6.8 AbbVie
- 6.8.1 AbbVie Company Information
- 6.8.2 AbbVie Business Overview
- 6.8.3 AbbVie Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 AbbVie Peptide Therapeutics Product Portfolio
- 6.8.5 AbbVie Recent Developments
- 6.9 Ipsen
- 6.9.1 Ipsen Company Information
- 6.9.2 Ipsen Business Overview
- 6.9.3 Ipsen Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Ipsen Peptide Therapeutics Product Portfolio
- 6.9.5 Ipsen Recent Developments
- 6.10 Ferring
- 6.10.1 Ferring Company Information
- 6.10.2 Ferring Business Overview
- 6.10.3 Ferring Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Ferring Peptide Therapeutics Product Portfolio
- 6.10.5 Ferring Recent Developments
- 6.11 Merck
- 6.11.1 Merck Company Information
- 6.11.2 Merck Business Overview
- 6.11.3 Merck Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Merck Peptide Therapeutics Product Portfolio
- 6.11.5 Merck Recent Developments
- 6.12 The Medicines
- 6.12.1 The Medicines Company Information
- 6.12.2 The Medicines Business Overview
- 6.12.3 The Medicines Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 The Medicines Peptide Therapeutics Product Portfolio
- 6.12.5 The Medicines Recent Developments
- 6.13 J & J
- 6.13.1 J & J Company Information
- 6.13.2 J & J Business Overview
- 6.13.3 J & J Peptide Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 J & J Peptide Therapeutics Product Portfolio
- 6.13.5 J & J Recent Developments
7 North America
- 7.1 North America Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Peptide Therapeutics Market Size by Country (2021-2026)
- 7.3 North America Peptide Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Peptide Therapeutics Market Size by Country (2021-2026)
- 8.3 Europe Peptide Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Peptide Therapeutics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Peptide Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Peptide Therapeutics Market Size by Country (2021-2026)
- 10.3 South America Peptide Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Peptide Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Peptide Therapeutics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Peptide Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst